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Abstract
The plasma concentration of indomethacin was measured after the rectal administration of
water-soluble and fatty base suppositories in rats. The results were compared with the in vitro
indomethacin release from suppositories determined by Paddle method using three different types
of membranes: cellulose membrane, artificial sausage membrane and natural sausage membrane.
The plasma concentrations of indomethacin during the first 4h after the rectal administration were
higher in rats that received water-soluble base suppositories than in those that received fatty base
types. When either a cellulose membrane or an artificial sausage membrane of cow protein was
used in the Paddle method, the amount of indomethacin released from fatty base suppositories
was significantly higher than that from water-soluble base ones. However, the results were re-
versed when a natural sausage membrane of pig colon was used. The discrepancy in the in vitro
experiments using water-soluble base suppositories seemed to be due to the difference of pore size
of membrane used. Careful consideration should be given to the membrane used in the Paddle
method especially when this method is employed to examine the release of poorly soluble drugs
like indomethacin in both water-soluble and fatty base suppositories.
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